Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Insight & Intelligence™

Related to HemaQuest Raises $13M to Fund Phase II Study with Sickle Cell/Thalassemia Drug

  • Blood Flow as Diagnostic Marker
    Jamming, or vaso-occlusion, could be used to distinguish sickle cell disease patients with poor outcomes from those with good outcomes.
  • Page 1 of 1 (1 items) 1 

GEN Poll

More » Poll Results » Archive »

Myriad Genetics Trial: Your Thoughts?

Do you agree with the Supreme Court’s decision in the Myriad case?

Suggest a Poll